Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Mesoblast
Company

Mesoblast

Tracked across 1 events · 9 articles · First seen Mar 11, 2026 · Last active Mar 11, 2026

Sentiment
20
Attention
2
Events
1
Relationships
3
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 20
Business
Mesoblast Appoints Teresa Montagut Head of Clinical Development
Mesoblast appointed Teresa Montagut as Head of Clinical Development and Medical Affairs, a move expected to enhance its cell therapy programs and expand indications for its FDA-approved product Ryoncil. This appointment is seen as a positive step for the company's strategic growth and pipeline advancement.
Mar 11, 2026 · 9 articles
Relationships (3)
Teresa Montagut Head of Clinical Development and Medical Affairs ↔ Mesoblast Teresa Montagut was appointed as Head of Clinical Development and Medical Affair
Eric Rose Chief Medical Officer ↔ Mesoblast Eric Rose is the Chief Medical Officer of Mesoblast, to whom Teresa Montagut wil
Silviu Itescu Chief Executive Officer ↔ Mesoblast Silviu Itescu is the Chief Executive Officer of Mesoblast.
NEWSDESK
Track Mesoblast live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.